That’s according to Aasmund Baklien, head of the pharmaceutical giant Novartis’ Norwegian division.
Within a few years a new and effective vaccine will come on to the market that will wage war against the disease that has cost Norwegian fish farmers close to NOK 6 billion (€766.6 million/$1.1 billion) in recent years.
The rule of thumb is that PD inflicts losses on Norwegian producers totalling around NOK 1 billion (€127.8 million/$184.9 million) per year. For a long time the statistics were fairly low, but graph curves began to shoot skywards as from 2004.
“On
